Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure there will be an adequate supply of Lisdexamphetamine in the event of the UK’s departure from the EU on 31 October 2019 without a deal.

The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans.

We were advised of a temporary supply issue affecting the Elvanse Adult presentation during September. However, this issue is now fully resolved and supplies of all presentations of lisdexamphetamine are currently available in quantities sufficient to meet normal demand.